© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

More articles

More articles

More articles

  • Innovent Biologics, the fourth issuer to ride the wave of Hong Kong’s biotechnology IPOs, was so popular with institutional investors that allocations caused a headache, said bankers.
  • Singapore’s Reit issuers are proving a resilient lot when it comes to fundraising in the equity markets, with the latest deal from Capitaland Mall Trust taking this year’s tally to $2.3bn.
  • Pietro Novelli, the new co-head of UBS Investment Bank, defended the co-head structure the firm opted for following the departure of Andrea Orcel to run Santander, against the charge from one analyst that "dual leadership never works".
  • RBC Capital Markets announced a series of hires in European real estate investment banking on Wednesday, part of the firm’s gradual expansion across industries in European IB.
  • Barclays announced this week that it is calling $2.65bn of retail preference shares. The bank said it is redeeming the instrument now, several years after the first call date, due to confidence in its capital position.
  • This month’s global equity sell-off has devastated markets and investors' performance for the year, and Europe’s large equity capital markets houses are thinking of calling time on a challenging 2018 to give a battered buy-side some time to recover, writes Sam Kerr.
shared comment list